CD2H COVID-19

Covid-19 Messaging to Underserved Communities - 2nd Experiment

Purpose

The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19. The sample will include African American and white adult Americans and oversample those with less than a college degree.

Condition

Covid19

Eligibility

Eligible Ages: Over 18 Years
Eligible Genders: All
Accepts Healthy Volunteers: Yes

Inclusion Criteria

adults who self-identify as African American or white. - an oversample of individuals with less than a college education

Exclusion Criteria

Study Design

Phase: N/A
Study Type: Interventional
Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Prevention
Masking: None (Open Label)

Arm Groups

Arm	Description	Assigned Intervention
Experimental AMA RI - B- B - R	Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will include information on the disproportionate impact on communities of color.	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: Racial Inequality Highlighted Investigators will include information on race-specific covid-19 cases and deaths in one variation in the messaging. In this arm, participants receive disproportionate race-specific Covid-19 facts
Experimental AMA RI - B - B - N	Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will not include information on the disproportionate impact on communities of color.	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: No Racial Inequality Highlighting In this arm, the disproportionate burden of Covid-19 on communities of color will not be highlighted
Experimental AMA RI - W - W - R	Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will include information on the disproportionate impact on communities of color.	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: Racial Inequality Highlighted Investigators will include information on race-specific covid-19 cases and deaths in one variation in the messaging. In this arm, participants receive disproportionate race-specific Covid-19 facts Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video
Experimental AMA RI - W - W - N	Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will not include information on the disproportionate impact on communities of color.	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video Behavioral: No Racial Inequality Highlighting In this arm, the disproportionate burden of Covid-19 on communities of color will not be highlighted
Experimental AMA DP - B- B - R	Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will include information on the disproportionate impact on communities of color .	Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: Racial Inequality Highlighted Investigators will include information on race-specific covid-19 cases and deaths in one variation in the messaging. In this arm, participants receive disproportionate race-specific Covid-19 facts Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing
Experimental AMA DP - B- B - N	Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will not include information on the disproportionate impact on communities of color.	Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing Behavioral: No Racial Inequality Highlighting In this arm, the disproportionate burden of Covid-19 on communities of color will not be highlighted
Experimental AMA DP - W- W - R	Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will include information on the disproportionate impact on communities of color.	Behavioral: Racial Inequality Highlighted Investigators will include information on race-specific covid-19 cases and deaths in one variation in the messaging. In this arm, participants receive disproportionate race-specific Covid-19 facts Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video
Experimental AMA DP - W- W - N	Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will not include information on the disproportionate impact on communities of color.	Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video Behavioral: No Racial Inequality Highlighting In this arm, the disproportionate burden of Covid-19 on communities of color will not be highlighted
Placebo Comparator Control: AMA RI - B - B	Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - No message on Covid-19 will be shown. Acknowledgement Racial Injustice AMA: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. African American Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: Placebo videos Videos not related to covid-19 will be shown
Placebo Comparator Control: AMA RI - W - W	Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will also be white - No message on Covid-19 will be shown. Acknowledgement Racial Injustice AMA: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. White Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a white sender in acknowledgment of AMA	Behavioral: Acknowledgement Racial Injustice AMA Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video Behavioral: Placebo videos Videos not related to covid-19 will be shown
Placebo Comparator Control: AMA DP - B - B	Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - No message on Covid-19 will be shown. African American Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA AMA Acknowledgement Drug Pricing: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing	Behavioral: African American Sender Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA Behavioral: African American Sender in Informational Videos. Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos. Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing Behavioral: Placebo videos Videos not related to covid-19 will be shown
Placebo Comparator Control: AMA DP - W - W	Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will also be white - No message on Covid-19 will be shown. White Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a white sender in acknowledgment of AMA AMA Acknowledgement Drug Pricing: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing	Behavioral: AMA Acknowledgement Drug Pricing Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing Behavioral: White Sender in Acknowledgement Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement Behavioral: White Sender in Informational Videos Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video Behavioral: Placebo videos Videos not related to covid-19 will be shown

Recruiting Locations

More Details

NCT ID: NCT04502056
Status: Completed
Sponsor: National Bureau of Economic Research, Inc.

Detailed Description

Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. Moreover, since our last experiment, the killing of George Floyd by Minnesota police has raised awareness of structural racism in the United States. The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19.The sample will include African American and white adult Americans and oversample those with less than a college degree.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.